Ellenberg SS - Search Results

1

Data monitoring committees: Promoting best practices to address emerging challenges.

Fleming TR, DeMets DL, Roe MT, Wittes J, Calis KA, Vora AN, Meisel A, Bain RP, Konstam MA, Pencina MJ, Gordon DJ, Mahaffey KW, Hennekens CH, Neaton JD, Pearson GD, Andersson TL, Pfeffer MA, Ellenberg SS. Fleming TR, et al. Among authors: ellenberg ss. Clin Trials. 2017 Apr;14(2):115-123. doi: 10.1177/1740774516688915. Epub 2017 Feb 1. Clin Trials. 2017. PMID: 28359194 Free PMC article.

2

The use of external monitoring committees in clinical trials of the National Institute of Allergy and Infectious Diseases.

Ellenberg SS, Myers MW, Blackwelder WC, Hoth DF. Ellenberg SS, et al. Stat Med. 1993 Mar;12(5-6):461-7; discussion 469. doi: 10.1002/sim.4780120510. Stat Med. 1993. PMID: 8493424

3

The data and safety monitoring board and acquired immune deficiency syndrome (AIDS) clinical trials.

DeMets DL, Fleming TR, Whitley RJ, Childress JF, Ellenberg SS, Foulkes M, Mayer KH, O'Fallon J, Pollard RB, Rahal JJ, et al. DeMets DL, et al. Among authors: ellenberg ss. Control Clin Trials. 1995 Dec;16(6):408-21. doi: 10.1016/s0197-2456(95)00073-9. Control Clin Trials. 1995. PMID: 8720018 Free article.

4

Statistical approaches and policies for the operations of Data and Safety Monitoring Committees.

Califf RM, Ellenberg SS. Califf RM, et al. Among authors: ellenberg ss. Am Heart J. 2001 Feb;141(2):301-5. doi: 10.1067/mhj.2001.113152. Am Heart J. 2001. PMID: 11174347 Review. No abstract available.

5

Independent data monitoring committees: rationale, operations and controversies.

Ellenberg SS. Ellenberg SS. Stat Med. 2001 Sep 15-30;20(17-18):2573-83. doi: 10.1002/sim.730. Stat Med. 2001. PMID: 11523070

6

Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop.

De Gruttola VG, Clax P, DeMets DL, Downing GJ, Ellenberg SS, Friedman L, Gail MH, Prentice R, Wittes J, Zeger SL. De Gruttola VG, et al. Among authors: ellenberg ss. Control Clin Trials. 2001 Oct;22(5):485-502. doi: 10.1016/s0197-2456(01)00153-2. Control Clin Trials. 2001. PMID: 11578783

7

Monitoring clinical trials: issues and controversies regarding confidentiality.

Fleming TR, Ellenberg S, DeMets DL. Fleming TR, et al. Stat Med. 2002 Oct 15;21(19):2843-51. doi: 10.1002/sim.1288. Stat Med. 2002. PMID: 12325100

8

Should statisticians reporting to data monitoring committees be independent of the trial sponsor and leadership?

Ellenberg SS, George SL. Ellenberg SS, et al. Stat Med. 2004 May 30;23(10):1503-5. doi: 10.1002/sim.1784. Stat Med. 2004. PMID: 15122727

9

Monitoring data on data monitoring.

Ellenberg SS. Ellenberg SS. Clin Trials. 2004 Feb;1(1):6-8. doi: 10.1191/1740774504cn001ed. Clin Trials. 2004. PMID: 16281457 No abstract available.

10

Issues in regulatory guidelines for data monitoring committees.

DeMets D, Califf R, Dixon D, Ellenberg S, Fleming T, Held P, Julian D, Kaplan R, Levine R, Neaton J, Packer M, Pocock S, Rockhold F, Seto B, Siegel J, Snapinn S, Stump D, Temple R, Whitley R. DeMets D, et al. Clin Trials. 2004;1(2):162-9. doi: 10.1191/1740774504cn019xx. Clin Trials. 2004. PMID: 16281888 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

226 results

Search Page

Filters